Garges is the Chief Medical Officer of ViiV Healthcare.
Apretude PrEP Shows High Efficacy, Safety in Diverse Studies
March 14th 2025New data at CROI 2025 shows zero cases of HIV acquisition reported with Apretude (cabotegravir long-acting (CAB LA) for PrEP in varied clinical settings and populations in 2 implementation studies in the US and Brazil.
Read More